Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
BMJ (Clinical Research Ed.)
|
November 19, 2005
Data are still needed for HPV immunisation programme
O Noel Gill, Catherine M Lowndes
BMJ (Clinical Research Ed.)
|
October 22, 2005
Cervical cancer, human papillomavirus, and vaccination
Catherine M Lowndes, O Noel Gill
The Lancet. Public Health
|
September 9, 2018
Estimating chlamydia prevalence: more difficult than modelling suggests
Kate Soldan, J Kevin Dunbar, O Noel Gill
Lancet (London, England)
|
August 4, 2009
HIV testing in the UK
Tim Chadborn, Valerie Delpech, Barry Evans, et al.
BMC Public Health
|
June 29, 2006
Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison
Andrew J Sutton, W John Edmunds, O Noel Gill
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
June 11, 2021
Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019
John Saunders, O Noel Gill, Valerie Delpech, et al.
Journal of Epidemiology and Community Health
|
March 1, 1991
BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England
L C Rodrigues, O Noel Gill, P G Smith
Lancet (London, England)
|
August 3, 2010
Human papillomavirus vaccine coverage
Sarika Desai, Kate Soldan, Joanne White, et al.
BMJ (Clinical Research Ed.)
|
September 7, 2012
Opportunistic or population register based programmes for chlamydia screening?
Angie Bone, Kate Soldan, Sarah Woodhall, et al.
Lancet (London, England)
|
November 26, 2013
HIV in the UK: test, test, and test again
Anthony Nardone, Valerie Delpech, O Noel Gill, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
BMJ (Clinical Research Ed.)
|
November 19, 2005
Data are still needed for HPV immunisation programme
O Noel Gill, Catherine M Lowndes
BMJ (Clinical Research Ed.)
|
October 22, 2005
Cervical cancer, human papillomavirus, and vaccination
Catherine M Lowndes, O Noel Gill
The Lancet. Public Health
|
September 9, 2018
Estimating chlamydia prevalence: more difficult than modelling suggests
Kate Soldan, J Kevin Dunbar, O Noel Gill
Lancet (London, England)
|
August 4, 2009
HIV testing in the UK
Tim Chadborn, Valerie Delpech, Barry Evans, et al.
BMC Public Health
|
June 29, 2006
Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison
Andrew J Sutton, W John Edmunds, O Noel Gill
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
June 11, 2021
Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019
John Saunders, O Noel Gill, Valerie Delpech, et al.
Journal of Epidemiology and Community Health
|
March 1, 1991
BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England
L C Rodrigues, O Noel Gill, P G Smith
Lancet (London, England)
|
August 3, 2010
Human papillomavirus vaccine coverage
Sarika Desai, Kate Soldan, Joanne White, et al.
BMJ (Clinical Research Ed.)
|
September 7, 2012
Opportunistic or population register based programmes for chlamydia screening?
Angie Bone, Kate Soldan, Sarah Woodhall, et al.
Lancet (London, England)
|
November 26, 2013
HIV in the UK: test, test, and test again
Anthony Nardone, Valerie Delpech, O Noel Gill, et al.
Page
of 6